Clinical Trial Update: Study With Aminophylline to Attenuate of the Side Effects of Regadenoson [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating aminophylline to reduce side effects of regadenoson (Lexiscan) in patients undergoing nuclear stress tests; the study was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Stress Testing-related Conditions
• Coronary Artery Disease
• Ischemia

Drugs mentioned

• Aminophylline (aminophylline)
• Regadenoson (Regadenoson)

Snippet

Sponsor: Rush University Medical Center | Conditions: Patients Being Assessed With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson, Lexiscan | Phase 4 | Status: TERMINATED | Results posted: 2023-03-13